NxStage Voluntary Sak Recall
Higher levels of endotoxin than NxStage tolerates were found in less than 1% of affected sak lots, so they notified patients who had those lots and issued a voluntary recall. An FDA recall was not required.
Read the full article » | Posted 02-15-2018
- Baxter Plans New Kidney Care Business for Growth and Innovation Posted 01-10-2023
- Outset Medical’s stock jumped 22.5% in December 2022 Posted 01-10-2023
- A Beginner’s Mindset Helped Leslie Trigg take Outset Medical to New Heights Posted 01-10-2023
- Quanta wins 2022 MacRobert Award Posted 12-19-2022